Delivery Order SPE2DB20D2014-SPE2DB26FA22Z
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,806.82 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors on August 26, 2025. This firm fixed price, non-competitive delivery order will be fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio serving...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a firm fixed price ceiling value of $48,324.15. The delivery order is set to be completed by September 23, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a competitively awarded, non-set-aside contract representing a continuation of AmerisourceBergen's ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dupixent 300 mg/2 ml pen injectors with a contract ceiling value of $15,432.15. This competitively awarded, firm fixed price delivery order is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a routine...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 ml pen injections with a ceiling value of $391,967.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $25,659.32 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on September 16, 2025, with completion expected by September 17, 2025. This non-competitive, firm fixed-price delivery order represents a procurement of specialty pharmaceutical products to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $13,018.75 under a firm fixed-price contract. The delivery order, which concludes on September 11, 2025, represents a competitively awarded non-set-aside procurement supporting the federal government's pharmaceutical supply requirements. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Dupixent 300 mg/2 ml pens with a ceiling value of $16,104.41. This non-competitive, firm fixed-price delivery order is scheduled for completion by September 5, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical pharmaceutical supplier to the federal government,...
- On August 5, 2025, the Defense Logistics Agency awarded a delivery order valued at $48,364.69 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a contract ceiling value of $8,830.13. This is a firm fixed-price delivery order issued without a set-aside designation, demonstrating AmerisourceBergen's ability to compete successfully in open procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Dupixent 300 mg/2 ml pen injections valued at $122,826.99. This firm fixed-price delivery order, with a completion date of September 26, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB26FA22ZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Dupixent 300 mg/2 mL pen injections with a ceiling value of $8,390.65. This firm fixed price, non-competitive delivery order is set to be completed by October 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial pharmaceutical supply relationship with the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. As a child contract under this substantial vehicle, the current delivery order exemplifies the company's role as a critical vendor for federal medical procurement, particularly in supplying specialty medications to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 10/30/25 |